Akouos licenses gene therapy tech from Massachusetts Eye and Ear

By Mary Romeo | Dec 8, 2017 | 2:53 AM GMT

Newco Akouos Inc. (Boston, Mass.) acquired an exclusive license to a vector platform from Massachusetts Eye and Ear (Boston, Mass.) and Lonza Group Ltd. (SIX:LONN) to develop gene therapies

Read the full 299 word article

How to gain access

Continue reading with a
two-week free trial.